NCT01131845View on ClinicalTrials.gov

The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Pulmonary Arterial HypertensionRenal Dysfunction
Interventions
DRUG

UT-15C SR (treprostinil diethanolamine)

Single dose, 1 mg UT-15C SR

Trial Locations (1)

32809

Orlando Clinical Research Center, Orlando

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY